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Towards human exploration of space: The THESEUS review
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Jean-Pol Frippiat1, Brian E Crucian2, Dominique J-F de Quervain3, Daniela Grimm4, Nicola Montano5, Siegfried Praun6,
Benno Roozendaal7, Gustav Schelling8, Manfred Thiel9, Oliver Ullrich10 and Alexander Choukèr8
Dysregulation of the immune system occurs during spaceﬂight and may represent a crew health risk during exploration missions
because astronauts are challenged by many stressors. Therefore, it is crucial to understand the biology of immune modulation
under spaceﬂight conditions in order to be able to maintain immune homeostasis under such challenges. In the framework of the
THESEUS project whose aim was to develop an integrated life sciences research roadmap regarding human space exploration,
experts working in the ﬁeld of space immunology, and related disciplines, established a questionnaire sent to scientists around the
world. From the review of collected answers, they deduced a list of key issues and provided several recommendations such as a
maximal exploitation of currently available resources on Earth and in space, and to increase increments duration for some ISS crew
members to 12 months or longer. These recommendations should contribute to improve our knowledge about spaceﬂight effects
on the immune system and the development of countermeasures that, beyond astronauts, could have a societal impact.
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INTRODUCTION
Spaceﬂight is a unique stress model impacted consistently or
intermittently by a myriad of stressors of psychosocial and physical
origin, high G forces at the time of launch and landing, increased
radiation, sleep deprivation and persistent circadian misalignment,
microgravity, and nutritional factors while in space. This multitude
of factors has profound immune modulatory effects on humans
and animals and can lead to certain types of immune dysregula-
tion with compromised defenses against infections, thereby
representing a potential barrier to long-term space exploration
(for more information consult recent reviews1–4). For example, 15
of the 29 Apollo astronauts contracted bacterial or viral infections
either during the mission or within a week of returning.5 Moreover,
recent results after mission to the International Space Station
revealed that during spaceﬂight some aspects of human immunity
may be oversensitized, as evidenced by some astronauts who
experienced prolonged allergic/skin hypersensitivity symptoms.6,7
Several studies have shown that spaceﬂight conditions induce
frequently hypoplasia of the spleen in rats and mice.8,9 Variations
in peripheral blood leukocyte subsets were also reported at
landing. These modiﬁcations could be mediated by changes in the
expression of adhesion molecules10,11 and/or the redistribution of
body ﬂuids in microgravity.12 An increase in the number of
peripheral blood neutrophils has been often observed. Results for
other cell types are variable thereby revealing the sensitivity of
immune cell populations to differences in spaceﬂight conditions,
post-ﬂight procedures, environmental inﬂuences, and experimen-
tal designs.
In the same way, it has been shown that the phagocytic and
oxidative functions of neutrophils are affected by spaceﬂight
conditions.13,14 Astronauts’ monocytes exhibit phenotypic and
cytokine-production deregulations and a reduced ability to engulf
E. coli, elicit an oxidative burst and degranulate.14–16 The response
of astronauts’ monocytes to Gram-negative endotoxins is
modulated by spaceﬂight-associated factors.17 Low natural killer
cell cytotoxicity and a delay in responses to hypersensitivity skin
tests were also observed.18–20 Moreover, reactivation of latent
herpes viruses (e.g., varicella zoster virus, cytomegalovirus, and
Epstein-Barr virus) has frequently been reported and is correlated
with a drop in interferon production and elevated levels of stress
hormones, suggesting that spaceﬂight-associated stressors may
be responsible for these reactivations.21–28 Latent virus reactiva-
tion can therefore be considered as a good biomarker of
spaceﬂight-induced weakening of cell-mediated immunity.
Similarly, the activation of T lymphocytes is severely depressed
under low-gravity conditions as highlighted by Cogoli’s team, which
performed many investigations on this topic following their
discovery of this phenomenon in 1984.29–33 This lower response
has several explanations. First, changes in gene expression as lower
expressions of Interleukin-2 (IL-2) and IL-2 receptor were observed
under real and simulated microgravity31–40 and it was shown that
gravity can regulate T-cell activation by blocking translation via
noncoding microRNA.41 Second, reduced cell–cell interactions and
cytoskeleton structure changes. Indeed, T lymphocytes motility was
found to be affected, the motility of monocytes was severely
reduced and the structure of their cytoskeleton was
modiﬁed.30,34,40,42–46 These motility and cytoskeleton changes
1Stress Immunity Pathogens Laboratory, EA7300, Lorraine University, Nancy, France; 2NASA Johnson Space Center, Houston, TX, USA; 3Departments of Medicine and Psychology,
University of Basel, Basel, Switzerland; 4Department of Biomedicine, Pharmacology, Aarhus University, Aarhus, Denmark; 5Cardiovascular Neuroscience Laboratory, Department of
Biomedical and Clinical Sciences, University of Milan, Milan, Italy; 6VF Services GmbH, Absam, Austria; 7Department of Cognitive Neuroscience, Radboud University Medical Centre
and Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands; 8Department of Anaesthesiology, ‘Stress and Immunity’ Laboratory,
University of Munich, Munich, Germany; 9Department of Anaesthesiology and Surgical Intensive Care Medicine, University Medical Center Mannheim, Medical Faculty Mannheim,
University of Heidelberg, Heidelberg, Germany and 10Institute of Anatomy, Faculty of Medicine, University of Zurich, Zurich, Switzerland.
Correspondence: J-P Frippiat (jean-pol.frippiat@univ-lorraine.fr)
Received 20 February 2016; revised 11 October 2016; accepted 13 October 2016
www.nature.com/npjmgrav
Published in cooperation with the Biodesign Institute at Arizona State University, with the support of NASA
could reduce the interaction between T lymphocytes and mono-
cytes, essential for delivering the costimulatory signal. Because the
cytoskeleton is involved in signal transduction47 and could be the
structure through which cells sense gravity,48 inhibition of T-cell
response could thirdly result from alterations in signaling events.
Hughes–Fulford’s group analyzed differential gene expression in
Concanavalin A and anti-CD28-activated human T cells36 and
discovered that the impaired induction of early genes regulated
primarily by transcription factors NF-κB, CREB, ELK, AP-1, and STAT1
contributes to T-cell dysfunction under altered gravity. They also
showed that the protein kinase A (PKA) signaling pathway is
downregulated under microgravity. As NF-κB, AP-1, and CREB are all
regulated by PKA, these ﬁndings indicate that PKA is a key player in
gravity-mediated modulation of T-cell activation. In accordance
with these results, a recent study conﬁrmed that the Rel/NF-κB
signaling pathway and the transcription of key immediate early
genes involved in T-cell activation are inhibited by microgravity.49
Fourth, the disturbed expression of cell cycle regulatory proteins50
and the induction of apoptosis51,52 could also contribute to
impaired T-cell activation in microgravity, whereas key proteins of
T-cell signal modules seemed not to be severely disturbed in
microgravity.53 Finally, post-ﬂight cytokine data collected from crew
members54 revealed a decrease in TH1 cytokine expression, which
can contribute to decreased natural immunity and suggests a TH2
cytokine shift. This TH2 shift represents a signiﬁcant clinical risk for
TH2-related autoimmune diseases, disease susceptibility related to
diminished cell-mediated immunity, as well as allergies and
hypersensitivities as recently demonstrated.6,7 Although a well-
characterized post-ﬂight phenomenon, immune dysregulation
occurs, and persists during spaceﬂight, conﬁrming in-ﬂight
dysregulation distinct from the inﬂuences of landing and read-
aptation following deconditioning.55,56
Humoral immunity has rarely been investigated in astronauts.
According to the few studies available, no signiﬁcant changes in
plasma levels of immunoglobulin were observed after short-term
spaceﬂights,10,14,57 but inconsistent results were reported after
long-duration missions. Konstantinova et al.58 reported increased
levels of serum immunoglobulin, particularly total IgA and IgG,
whereas Rykova et al.14 indicated that the total amounts of serum
IgA, IgG, and IgM were unchanged after prolonged missions.
Furthermore, nothing is known about B-cell activation under
spaceﬂight conditions. Only studies performed using ground-
based analogs have been reported.32,59 Studies performed with
the urodele amphibian Pleurodeles waltl as animal model conﬁrmed
the increase of neutrophils in peripheral blood at landing.60 As for
astronauts, this increase can be attributed to stress because it was
shown that neutrophilia occurs in the urodele amphibian
Notophthalamus viridescens when it is treated with hydrocortisone
or adrenocorticotropic hormone (ACTH), two stress hormones, or
when it is subjected to environmental stress.61 Amphibians are
interesting models for analyzing the effects of spaceﬂight on the
immune system because cardinal elements of the adaptive immune
system are shared by all gnathostomes.1,62–69 Later on, adult P. waltl
were immunized with protein onboard the Mir space station. The
analysis of these animals revealed an increase of IgY heavy chain
mRNAs (IgY is the physiological counterpart of human IgA66) in the
spleen of ﬂown animals.70 This increase supports previous
observations made in astronauts by Konstantinova et al.58
Furthermore, these animals allowed demonstrating that spaceﬂight
affects antibody production in response to an antigenic stimulation.
Indeed, the use of the different VH gene subgroups69 and the
expression of individual VH gene segments71 were observed to be
modiﬁed under spaceﬂight conditions. In addition, these animals
enabled, for the ﬁrst time, the demonstration that somatic
hypermutations, which diversify antibody binding sites to improve
their afﬁnity, occur in space following immunization but at a lower
frequency.72 This observation suggests that antibody afﬁnity
maturation could be less efﬁcient in space, thereby decreasing
the efﬁciency of the immune response. Finally, it was noted that the
transcription levels of IgM heavy chains and of an early B-cell
transcription factor are modiﬁed when P. waltl embryos are
subjected to gravity changes, suggesting a modiﬁcation in
lymphopoiesis.73 This hypothesis was then conﬁrmed in mice
subjected to ground-based models.74,75
In parallel, changes in microbial growth characteristics and
pathogenicity have been observed for several microorganisms
during spaceﬂight.76–80 These data, coupled to dysregulations of
the immune system, suggest that opportunities for microbes to
establish foci of infection could be enhanced during space
missions (Figure 1). Furthermore, some data suggest that
antibiotics could be less effective in space.81
Finally, it was shown that spaceﬂight induces signiﬁcant changes
in the thymic mRNA expression of genes that regulate stress and
glucocorticoid receptor metabolism.82 To better approach the
consequences of physical and emotional stressors in man exposed
to spaceﬂight, investigations have been undertaken by applying
virulence, resistance
& proliferation
immune performance
Stressors encountered during spaceflight (microgravity, radiation, chronic stress, fluid
shear, hydrostatic pressure, etc.) weaken the immune system and have a positive impact
on some pathogens
Figure 1. Numerous dysregulations of the immune system have been reported during and following spaceﬂight. In parallel, spaceﬂight has
been shown to increase the virulence, antibiotic resistance, and proliferation of some pathogens suggesting that susceptibility to infections
could be enhanced during space missions.
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complementary and elaborated blood, urine and saliva sampling,
and analyses, together with questionnaires based emotional stress
monitoring. These investigations in man ranged from very acute
gravitational challenges (parabolic ﬂight) to short (1–2 weeks) and
long (4–7 months) duration ISS missions and showed that there is a
shift from an alert state of primed innate immune cells after acute
gravitational stress to a decrease of their activity after spaceﬂight.
Adrenocortical stress-responses suggest that sympathetic nervous
system (SNS) responses predominate after short spaceﬂights,
although long ﬂights are characterized by glucocorticoid-
mediated changes. Furthermore, central activation of SNS, even
via non-adrenomedullary pathways, such as sleep deprivation,83
has recently been shown to have a pivotal role in the regulation of
inﬂammation84 and innate immunity.85 The immunotropic endo-
cannabinoid system is also activated under acute gravitational
stress and in space.86 Further, Earth-bound studies have provided
evidence of emotional stress-sensitive immune changes in
human.54,86–88 These data highlight the complex systemic com-
promise of the immune system in response to exposure to multiple
stressors during spaceﬂight (Figure 2).
Altogether, these data indicate that spaceﬂight-induced altera-
tions of the immune system have the potential to be a serious
clinical risk to astronauts and cosmonauts during exploration-class
deep space missions beyond Earth orbit.3,89 This represents an
area that should be considered more thoroughly, via both ground-
analog studies and investigations onboard the ISS, to ensure long-
term survival in space stations and sustain habitation during
future missions to the moon, Asteroids, or on any planet i.e., Mars.
IDENTIFIED KEY ISSUES
Consequently, experts working in the ﬁeld of space immunology
and experts working in related areas (e.g., psychoneuroendocrine
and autonomous nervous system regulation) established a
questionnaire that was sent to scientists around the world to
identify key issues that should be addressed for the preparation of
future long-duration space missions. The analysis of collected
answers highlighted the following points:
● The identiﬁcation and the quantiﬁcation of stress factors
encountered during a space mission and their impact on the
immune system should be better studied.
● The extension of ISS increments to 1 year or longer is of
importance to address the following questions: (i) are immune
system development, response, and regulation as efﬁcient in
space (ISS/moon/Mars) as on Earth? (ii) What are the con-
sequences of chronic immune changes on disease during and
after long-duration missions? (iii) What are the consequences of
long-duration (⩾1 year) missions on the degree of immunosup-
pression/modulation? (iv) What effects Lunar or Mars dusts,
habitat environment and other chemicals, have on immune
system performance?
● Are stress-dependent virus reactivation patterns linked to
cancer development?
● The interaction between the immune system and other stress-
sensitive systems (neurophysiological and others) should be
further studied.
● The deﬁnition and testing of countermeasures.
In order to understand and track the footprint of space
exploration on the immune system, and its interactions with
other organs, it appears crucial that these key issues are addressed
through an appropriate technical and structural framework. In this
context, three interlinked approaches emerged: (i) pathophysio-
logical cellular pathways and complex molecular mechanisms
analysis using isolated cell systems. (ii) Implementation of animal
experiments to investigate the compromise of the immune system
after exposure to multiple stressors encountered during space-
ﬂight. (iii) Coordinated investigations in man to better approach
the consequences of multifactorial effects of physical stressors and
emotional stress induced by spaceﬂight.
KNOWLEDGE GAPS AND RESEARCH NEEDS IDENTIFIED BY THE
ONLINE SURVEY
In light of future manned spaceﬂight for exploration, extension of
ISS increments for some ISS astronauts/cosmonauts to one year or
longer has been considered by all Expert Group (EG) members, and
the majority of investigators participating to the online consulta-
tion, of very high importance. It is fortunate that the ﬁrst 1-year ISS
expedition has been successfully accomplished and may pave the
way for further repeat or an even further prolongation.
The development of inﬂight hardware to perform easy-to-
handle and noninvasive exams to monitor immune and hemo-
static changes was considered to be of very high importance by
EG as well as by 90% of the consulted specialists. Indeed, up to
now, due to technical constrains and limited astronaut time
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Figure 2. Interlinks between the central nervous system and the immune system. ANS, autonomic nervous system; IL, interleukin; PNS,
peripheral nervous system; SNS, sympathetic nervous system; TNF-α, tumor necrosis factor α.
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dedicated to each experiment, most inﬂight assessments resulted
from the analysis of inﬂight ﬁxed cells.
To achieve a higher relevance of gathered data, especially for
critical investigations, a need for (i) repeating inﬂight experiments
at least twice and (ii) some standardization of experiment design,
methods, assays, and so on is requested. Both points were
considered of high or very high importance by490% of consulted
scientists.
Before going to space, test and control experiments should be
performed using the full scale of Earth-bound models that can
adequately simulate speciﬁc spaceﬂight conditions. Fifty percent
of the respondents considered this point as very highly relevant
and 40% as highly relevant. The appropriate terrestrial analog may
vary based on the space-physiological system of interest. For
immune dysregulation Arctic, undersea, and Antarctica deploy-
ment have all be demonstrated to have similarities to ﬂight.
Prolonged head-down tilt bed rest can also be used. However,
conﬂicting results have been reported using this model; some
studies reported limited changes in the immune system,90,91
whereas others reported changes in cytokine production, immune
cell activation and innate immunity.92–97
The establishment of a bank of tissue and plasma samples
available to the scientiﬁc community was deﬁned by the majority
of EG members and external experts (490%) to be very important
to extract maximal information as well as to reanalyze samples
when new tools become available.
Taking advantage of health data ﬁles from ISS crew members,
with retrospective and prospective access, is necessary to estimate
clinically relevant changes in regard to immune alterations.
PROPOSED INVESTIGATIONS AND RECOMMENDATIONS
Given these knowledge gaps and research needs, the expert
group established a list of recommendations:
● The immune system is a target and a sensor of environmental
changes affecting the organism as a whole. Therefore, inter-
disciplinary approaches are required to understand how home-
ostasis and immune functions are affected through other organs
under acute or chronic stress conditions, both in space and
on Earth.
● Multidisciplinary approaches should include the full-scale use of
available in vitro and in vivo methods using rodents or other
animal models, as well as clinical and space related Earth-bound
studies.
● It is highly recommended to standardize some methodologies
used for immune research as well as repeating space
experiments.
● The establishment of an all ISS-partners international biological
sample archive (samples collected from space crew members
and animals) is mandatory to allow the extraction of a maximum
of information from these samples. Such a sample archive would
be most beneﬁcial if multiple types of biological samples, such as
saliva, urine, plasma, and blood cells could be appropriately
preserved for various soluble, cellular and/or molecular analyses.
● The access to anonym health data from crew members,
retrospectively and prospectively, should be allowed to
complete space experiments results.
● The development of new technologies to diagnostic immune
changes in minute amounts of blood should be encouraged.
Preliminary efforts to develop such microgravity-compatible
laboratory instruments have been initiated both in Europe and
in North America and should be continued because such
hardware would be a beneﬁt for space and Earth medicine.
TRANS- AND CROSS-DISCIPLINARY ASPECTS
The understanding of stress related immune challenges in space is
of high relevance to understand the biology of cancer, immunol-
ogy and inﬂammation in astronauts as well as in the young and
ageing population on Earth. The translational aspects of techno-
logical developments for space research constitute also a
potentially highly attractive spin-off for, e.g., the non-invasive
monitoring of immune and health conditions in minute amounts
of blood in space and on Earth. Finally, the immune system is one
of the largest and most widespread systems with hormonal and
neuronal connections (Figure 2). The immune system is strongly
linked with almost every organ homeostasis and can be affected,
together with other systems, upon stress challenges. As an
example, stress induces the secretion of hormones which can
modulate immune responses and also promote bone turnover.
Moreover, immune responses are susceptible to exercise and
nutritional factors as well as to environmental factors like
radiation, the microbial load and the oxygen tension in the
habitat. Therefore, there are manifold non-selective interactions
with other ﬁelds and topics such as bone, muscle, kidney, lung,
neurophysiology, cognitive performance, nutrition, exercise, the
cardiovascular system, habitat environment and design, radiation,
and health (prevention, diagnosis, and therapy). Consequently,
several types of countermeasures could be tested that affect
directly or indirectly the immune system such as vaccination,
nutrition, exercise but also pharmacological and psychosocial
approaches dedicated to reducing stress because it is an
important contributor to immune dysfunction. These counter-
measures are also interesting for other conditions in which the
function of the immune system is compromised on Earth such as
people subjected to acute or chronic stress.
CONCLUSION AND EARTH BENEFITS
It is an international scope to gather more knowledge on how the
immune system is webbed in the pathology and clinical
appearance of disease, from it cellular functions to an orchestrated
action of immune functions in the complex human system. In the
ﬁelds of fundamental and clinical immunology, the analyses of the
links with other organs are important to address societal questions
such as aging and the consequences of a sedentary life style. From
clinical investigations in the healthy and the sick, the lifesaving
importance of adequate immunity at the switch between the host
and the environment was never clearer before. On-orbit immune
dysregulation has the potential to be of either a “hyper” or a
“hypo” nature, or even both as various innate and adaptive cellular
components may respond differently during ﬂight. Beside
controlling infections and eliminating germs, immunological
responses are also capable of eliminating non-functional or
dysfunctional cells, e.g., tumor cells. Failure to establish adequate
immune answers and to distinguish between ‘self’ and ‘non-self’
can result in autoimmune diseases (e.g., rheumatoid arthritis),
acute and life-threatening infections and overwhelming systemic
immune responses (e.g., septicemia) or the development of
cancer. Changes to this endogenous balance between the
immune and other systems due to psychological or environmental
factors can impact this ﬁnely balanced, endo-, para-, and
autocrine-controlled immune function, resulting in immune
dysfunction and disease. The understanding of these deregula-
tions, together with the development of appropriate counter-
measures, can help space travelers and people on Earth.
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